110 related articles for article (PubMed ID: 17050255)
1. In vitro expansion of Ag-specific T cells by HLA-A*0201-transfected K562 cells for immune monitoring.
Yuan J; Gallardo HF; Rasalan T; Ranganathan R; Wang J; Zhang Y; Panageas K; Stan R; Young JW; Houghton AN; Wolchok JD
Cytotherapy; 2006; 8(5):498-508. PubMed ID: 17050255
[TBL] [Abstract][Full Text] [Related]
2. A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation.
Hida N; Maeda Y; Katagiri K; Takasu H; Harada M; Itoh K
Cancer Immunol Immunother; 2002 Jun; 51(4):219-28. PubMed ID: 12012109
[TBL] [Abstract][Full Text] [Related]
3. The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays.
Britten CM; Meyer RG; Kreer T; Drexler I; Wölfel T; Herr W
J Immunol Methods; 2002 Jan; 259(1-2):95-110. PubMed ID: 11730845
[TBL] [Abstract][Full Text] [Related]
4. The use of clonal mRNA as an antigenic format for the detection of antigen-specific T lymphocytes in IFN-gamma ELISPOT assays.
Britten CM; Meyer RG; Frankenberg N; Huber C; Wölfel T
J Immunol Methods; 2004 Apr; 287(1-2):125-36. PubMed ID: 15099761
[TBL] [Abstract][Full Text] [Related]
5. Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
Christensen O; Lupu A; Schmidt S; Condomines M; Belle S; Maier A; Hose D; Neuber B; Moos M; Kleist C; Terness P; Ho AD; Goldschmidt H; Klein B; Hundemer M
J Immunother; 2009; 32(6):613-21. PubMed ID: 19483648
[TBL] [Abstract][Full Text] [Related]
6. Efficient presentation of naturally processed HLA class I peptides by artificial antigen-presenting cells for the generation of effective antitumor responses.
Hirano N; Butler MO; Xia Z; Berezovskaya A; Murray AP; Ansén S; Nadler LM
Clin Cancer Res; 2006 May; 12(10):2967-75. PubMed ID: 16707591
[TBL] [Abstract][Full Text] [Related]
7. A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples.
Jackson HM; Dimopoulos N; Chen Q; Luke T; Yee Tai T; Maraskovsky E; Old LJ; Davis ID; Cebon J; Chen W
J Immunol Methods; 2004 Aug; 291(1-2):51-62. PubMed ID: 15345304
[TBL] [Abstract][Full Text] [Related]
8. Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.
Suneetha PV; Schlaphoff V; Wang C; Stegmann KA; Fytili P; Sarin SK; Manns MP; Cornberg M; Wedemeyer H
J Immunol Methods; 2009 Mar; 342(1-2):33-48. PubMed ID: 19135447
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.
Stronen E; Abrahamsen IW; Gaudernack G; Wälchli S; Munthe E; Buus S; Johansen FE; Lund-Johansen F; Olweus J
Scand J Immunol; 2009 Apr; 69(4):319-28. PubMed ID: 19284496
[TBL] [Abstract][Full Text] [Related]
10. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
[TBL] [Abstract][Full Text] [Related]
11. Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells.
Paine A; Oelke M; Blasczyk R; Eiz-Vesper B
Transfusion; 2007 Nov; 47(11):2143-52. PubMed ID: 17958544
[TBL] [Abstract][Full Text] [Related]
12. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.
Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H
Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861
[TBL] [Abstract][Full Text] [Related]
13. T-cell responses to multiple antigens presented by RNA-transfected APCs: a possible immunomonitoring tool.
Bartido SM; Zier K
Cancer Immunol Immunother; 2004 Feb; 53(2):100-9. PubMed ID: 13680195
[TBL] [Abstract][Full Text] [Related]
14. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
[TBL] [Abstract][Full Text] [Related]
15. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.
Lu ZY; Condomines M; Tarte K; Nadal L; Delteil MC; Rossi JF; Ferrand C; Klein B
Exp Hematol; 2007 Mar; 35(3):443-53. PubMed ID: 17309825
[TBL] [Abstract][Full Text] [Related]
16. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
Lundberg K; Roos AK; Pavlenko M; Leder C; Wehrum D; Guevara-Patiño J; Andersen RS; Pisa P
Vaccine; 2009 Mar; 27(10):1557-65. PubMed ID: 19171173
[TBL] [Abstract][Full Text] [Related]
17. Activated B cells mediate efficient expansion of rare antigen-specific T cells.
Zentz C; Wiesner M; Man S; Frankenberger B; Wollenberg B; Hillemanns P; Zeidler R; Hammerschmidt W; Moosmann A
Hum Immunol; 2007 Feb; 68(2):75-85. PubMed ID: 17321896
[TBL] [Abstract][Full Text] [Related]
18. Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity.
Strauss G; Osen W; Knape I; Jacobsen EM; Müller SM; Debatin KM
Cell Death Differ; 2007 Mar; 14(3):480-8. PubMed ID: 16902496
[TBL] [Abstract][Full Text] [Related]
19. An APC for every occasion: induction and expansion of human Ag-specific CD4 and CD8 T cells using cellular and non-cellular APC.
Grübe M; Melenhorst JJ; Barrett AJ
Cytotherapy; 2004; 6(5):440-9. PubMed ID: 15512910
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients.
Vikman S; Giandomenico V; Sommaggio R; Oberg K; Essand M; Tötterman TH
Cancer Immunol Immunother; 2008 Mar; 57(3):399-409. PubMed ID: 17717663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]